Literature DB >> 20303412

NO synthase: structures and mechanisms.

Simon Daff1.   

Abstract

Production of NO from arginine and molecular oxygen is a complex chemical reaction unique to biology. Our understanding of the chemical and regulation mechanisms of the NO synthases has developed over the past two decades, uncovering some extraordinary features. This article reviews recent progress and highlights current issues and controversies. The structure of the enzyme has now been determined almost in entirety, although it is as a selection of fragments, which are difficult to assemble unambiguously. NO synthesis is driven by electron transfer through FAD and FMN cofactors, which is controlled by calmodulin binding in the constitutive mammalian enzymes. Many of the unique structural features involved have been characterised, but the mechanics of calmodulin-dependent activation are largely unresolved. Ultimately, NO is produced in the active site by the reaction of arginine with activated heme-bound oxygen in two distinct cycles. The unique role of the tetrahydrobiopterin cofactor as an electron donor in this process has now been established, but the subsequent chemical events are currently a matter of intense speculation and debate. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303412     DOI: 10.1016/j.niox.2010.03.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  68 in total

1.  Pulsed ENDOR determination of the arginine location in the ferrous-NO form of neuronal NOS.

Authors:  Andrei V Astashkin; Bradley O Elmore; Li Chen; Weihong Fan; J Guy Guillemette; Changjian Feng
Journal:  J Phys Chem A       Date:  2012-06-15       Impact factor: 2.781

2.  Pulsed ENDOR determination of relative orientation of g-frame and molecular frame of imidazole-coordinated heme center of iNOS.

Authors:  Andrei V Astashkin; Weihong Fan; Bradley O Elmore; J Guy Guillemette; Changjian Feng
Journal:  J Phys Chem A       Date:  2011-08-26       Impact factor: 2.781

3.  Single-molecule spectroscopy reveals how calmodulin activates NO synthase by controlling its conformational fluctuation dynamics.

Authors:  Yufan He; Mohammad Mahfuzul Haque; Dennis J Stuehr; H Peter Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-26       Impact factor: 11.205

4.  Fluorescence quenching studies of structure and dynamics in calmodulin-eNOS complexes.

Authors:  David C Arnett; Anthony Persechini; Quang-Kim Tran; D J Black; Carey K Johnson
Journal:  FEBS Lett       Date:  2015-04-11       Impact factor: 4.124

5.  A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.

Authors:  Linlin Zhong; Tuan Tran; Tyler D Baguley; Sang Jun Lee; Adam Henke; Andrew To; Sijia Li; Shan Yu; Fabio A Grieco; Jason Roland; Peter G Schultz; Decio L Eizirik; Nikki Rogers; Arnab K Chartterjee; Matthew S Tremblay; Weijun Shen
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

6.  Endothelial nitric-oxide synthase (eNOS) is activated through G-protein-coupled receptor kinase-interacting protein 1 (GIT1) tyrosine phosphorylation and Src protein.

Authors:  Songling Liu; Richard T Premont; Don C Rockey
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

Review 7.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

8.  Methylated N(ω)-hydroxy-L-arginine analogues as mechanistic probes for the second step of the nitric oxide synthase-catalyzed reaction.

Authors:  Kristin Jansen Labby; Huiying Li; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  Biochemistry       Date:  2013-04-26       Impact factor: 3.162

Review 9.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

Review 10.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.